Laboratorios Rubio S.A.
PolandAll drugs from this manufacturer
-
The medicine is used for the treatment of attention deficit hyperactivity disorder (ADHD) in children and adolescents aged 6 to 18 years and in adults.
Dosage form: capsules, hard modified release
Active substance Dosage methylphenidate hydrochloride 10 mg ATC: N06BA04
-
The medicine is used to treat attention deficit hyperactivity disorder (ADHD) in children and adolescents aged 6 to 18 years and in adults. It is used when previous methods, such as behavioral therapy or psychological counseling, have proven insufficient.
Dosage form: capsules, hard modified release
Active substance Dosage methylphenidate hydrochloride 20 mg ATC: N06BA04
-
It is used in the treatment of attention deficit hyperactivity disorder (ADHD) in children, adolescents, and adults. It may help improve attention and concentration and reduce impulsive behavior.
Dosage form: capsules, hard modified release
Active substance Dosage methylphenidate hydrochloride 30 mg ATC: N06BA04
-
The medicine is used to treat attention deficit hyperactivity disorder (ADHD) in children and adolescents aged 6 to 18 years and in adults. It is used when previous methods, such as behavioral therapy or psychological counseling, have proven insufficient.
Dosage form: capsules, hard modified release
Active substance Dosage methylphenidate hydrochloride 40 mg ATC: N06BA04